title: Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
authors.forename: R C
authors.initials: RC
authors.lastname: Finch
authors.forename: A P
authors.initials: AP
authors.lastname: Holliday
authors.forename: A
authors.initials: A
authors.lastname: Innes
authors.forename: R P
authors.initials: RP
authors.lastname: Burden
authors.forename: A G
authors.initials: AG
authors.lastname: Morgan
authors.forename: P N
authors.initials: PN
authors.lastname: Shaw
authors.forename: I
authors.initials: I
authors.lastname: Harding
authors.forename: M C
authors.initials: MC
authors.lastname: Wale
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001398:Aztreonam / Q000008:administration & dosage / Q000627:therapeutic use; D015314:Dialysis Solutions / Q000737:chemistry; D006801:Humans; D008997:Monobactams / Q000008:administration & dosage / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D017334:Teicoplanin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D015314:Dialysis Solutions; D008997:Monobactams; D017334:Teicoplanin; D001398:Aztreonam